Castle Biosciences, Inc. CSTL
NASDAQ · United States · Health Technology
$35.26-0.27 (-0.77%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-07-30 | -0.07 | -0.41 | +82.8% | $103.55M | +20.1% | +14.5%$24.46→$28.00 |
| Q1 2026 | 2026-05-06 | -0.49 | -0.56 | +12.5% | — | — | -21.8%$24.60→$19.24 |
| Q4 2025 | 2026-02-26 | -0.08 | -0.23 | +65.2% | — | — | -4.1%$30.83→$29.57 |
| Q3 2025 | 2025-11-03 | -0.02 | -0.34 | +94.1% | — | — | +24.0%$25.50→$31.63 |
| Q1 2025 | 2025-05-05 | -0.90 | -0.07 | -1,185.7% | — | — | — |
| Q2 2024 | 2024-08-05 | 0.31 | -0.24 | +229.2% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.